3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Colorectal Neoplasms
3
Small Cell Lung Carcinoma
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urinary Bladder Neoplasms
1
Spinocerebellar Degenerations
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma
1
PD-L1-selected Solid Tumors
1
Melanoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Chordoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Advanced Solid Malignancies
1
Advanced Rare Malignant Solid Neoplasm
1
Advanced Liver Cancers
1
Interventions
Oxaliplatin
66
pembrolizumab
48
Fluorouracil
44
Capecitabine
39
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
21
Docetaxel
19
Cisplatin
18
S 1 (combination)
17
Bevacizumab
15
Irinotecan
14
Drug Therapy
14
Ramucirumab
13
tislelizumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
sintilimab
9
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
atezolizumab
8
Specimen Handling
8
Biopsy
8
durvalumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Tiragolumab
×
1 year
×
Clear all
No trials found.